Steven Kayser • UCSF Profiles (original) (raw)

  1. Use Patterns and Unlabeled Uses of Target-Specific Oral Anticoagulants: A Single-Center Experience. J Pharm Technol. 2015 Oct; 31(5):204-211. Lin SY, Do LV, Kayser SR, Shin J. PMID: 34860912; PMCID: PMC5990191.
    View in: PubMed Mentions:
  2. In reply. JAMA Intern Med. 2013 Aug 12; 173(15):1473. Alldredge BK, Kayser SR. PMID: 24151653.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  3. Bending the curve toward increased use of generic drugs. JAMA Intern Med. 2013 Feb 11; 173(3):233-4. Alldredge BK, Kayser SR. PMID: 23303368.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  4. Key articles and guidelines in the management of pulmonary arterial hypertension: 2011 update. Pharmacotherapy. 2012 Jun; 32(6):e134-69. Johnson SG, Kayser SR, Attridge RL, Duvall L, Kiser TH, Moote R, Reed BN, Rodgers JE, Erstad B. PMID: 22467427.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  5. Accuracy of the pharmacogenetic dosing table in the warfarin label in predicting initial therapeutic warfarin doses in a large, racially diverse cohort. Pharmacotherapy. 2011 Sep; 31(9):863-70. Shin J, Kayser SR. PMID: 21923587.
    View in: PubMed Mentions: 5 Fields:
    Translation:Humans
  6. Pros and cons of dabigatran. Am J Health Syst Pharm. 2011 Aug 15; 68(16):1495. Cheng CM, McCurdy MR, Wong HA, Kayser SR. PMID: 21817080.
    View in: PubMed Mentions: 2 Fields:
    Translation:Humans
  7. Emergency department management of patients on warfarin therapy. Ann Emerg Med. 2011 Aug; 58(2):192-9. Meeker E, Dennehy CE, Weber EJ, Kayser SR. PMID: 21481971.
    View in: PubMed Mentions: 3 Fields:
    Translation:Humans
  8. Survey on warfarin pharmacogenetic testing among anticoagulation providers. Pharmacogenomics. 2009 Nov; 10(11):1853-60. Kadafour M, Haugh R, Posin M, Kayser SR, Shin J. PMID: 19891559.
    View in: PubMed Mentions: 12 Fields:
    Translation:Humans
  9. Pharmacogenetics: from discovery to patient care. Am J Health Syst Pharm. 2009 Apr 01; 66(7):625-37. Shin J, Kayser SR, Langaee TY. PMID: 19299369.
    View in: PubMed Mentions: 15 Fields:
    Translation:Humans
  10. Clinical pharmacy consultation for pharmacogenetic testing. Per Med. 2009 Mar; 6(2):183-192. Shin J, Kayser SR. PMID: 29788609.
    View in: PubMed Mentions: 2 Fields:
  11. A review of three stand-alone topical thrombins for surgical hemostasis. Clin Ther. 2009 Jan; 31(1):32-41. Cheng CM, Meyer-Massetti C, Kayser SR. PMID: 19243705.
    View in: PubMed Mentions: 18 Fields:
    Translation:HumansAnimals
  12. The use of nesiritide in the management of acute decompensated heart failure. 2002. Prog Cardiovasc Nurs. 2007; 22(4):89-95. Kayser SR. PMID: 18172951.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  13. Dronedarone: in quest of the ideal antiarrhythmic drug. Prog Cardiovasc Nurs. 2007; 22(4):221-4. Kayser SR. PMID: 18059201.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  14. Pharmacogenomics and the potential for personalized therapeutics in cardiovascular disease. Prog Cardiovasc Nurs. 2007; 22(2):104-7. Kayser SR. PMID: 17541322.
    View in: PubMed Mentions: 1 Fields:
    Translation:Humans
  15. Heart transplantation and altered drug response, part I: heart transplantation and innervation. Prog Cardiovasc Nurs. 2006; 21(2):100-3. Boettger R, Lee J, Rifkin C, Kayser S. PMID: 16760694.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  16. Heart transplantation and altered drug response, Part II: pharmacologic management of post-transplantation complications. Prog Cardiovasc Nurs. 2006; 21(4):219-22. Boettger R, Lee J, Rifkin C, Kayser SR. PMID: 17170599.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  17. The influence of ethnicity on warfarin dosage requirement. Ann Pharmacother. 2005 Jun; 39(6):1008-12. Dang MT, Hambleton J, Kayser SR. PMID: 15855242.
    View in: PubMed Mentions: 54 Fields:
    Translation:Humans
  18. Practical challenges in the management of oral anticoagulation. Prog Cardiovasc Nurs. 2005; 20(2):80-5. Kayser SR. PMID: 15886552.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  19. Combination drug therapy in the management of pulmonary arterial hypertension. Prog Cardiovasc Nurs. 2005; 20(4):177-82. Kayser SR. PMID: 16276142.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  20. Impact of pharmacists' interventions on the pediatric discharge medication process. Ann Pharmacother. 2004 Oct; 38(10):1597-602. Voirol P, Kayser SR, Chang CY, Chang QL, Youmans SL. PMID: 15328395.
    View in: PubMed Mentions: 7 Fields:
    Translation:HumansCTClinical Trials
  21. Famotidine and long QT syndrome. Am J Cardiol. 2004 May 15; 93(10):1325-7. Lee KW, Kayser SR, Hongo RH, Tseng ZH, Scheinman MM. PMID: 15135720.
    View in: PubMed Mentions: 13 Fields:
    Translation:Humans
  22. Dilemmas in drug therapy. Prog Cardiovasc Nurs. 2003; 18(2):108-11. Kayser SR. PMID: 12732804.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  23. Thrombocytopenia associated with antithrombotic therapy in acute coronary syndrome. Prog Cardiovasc Nurs. 2003; 18(4):198-200. Ho R, Kayser SR. PMID: 14605523.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  24. Therapeutic equivalency of low-molecular-weight heparins. Ann Pharmacother. 2002 Jun; 36(6):1042-57. McCart GM, Kayser SR. PMID: 12022908.
    View in: PubMed Mentions: 8 Fields:
    Translation:HumansAnimals
  25. The use of nesiritide in the management of acute decompensated heart failure. Prog Cardiovasc Nurs. 2002; 17(2):89-95. Kayser SR. PMID: 11986542.
    View in: PubMed Mentions: 2 Fields:
    Translation:Humans

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

Start with: newest oldestInclude: line numbers double spacing all authors publication IDs